The Food and Drug Administration yesterday posted a list of COVID-19 antibody tests that will no longer be marketed because they have not been authorized for emergency use under its revised policy, or the manufacturer withdrew them from the list of tests under review for emergency use.

To help ensure COVID-19 antibody tests are trustworthy, the agency revised its guidance May 4 to recommend manufacturers request an emergency use authorization within 10 business days after they validate their test.

Related News Articles

Headline
President Biden today announced new actions to spur more vaccinations nationwide against COVID-19, due in part to the rise of the SARS-CoV-2 delta variant.…
Headline
The AHA today released new Spanish-language public service announcements and related content pieces to support vaccination efforts and complement previously…
Headline
AHA today urged the Centers for Medicare & Medicaid Services to make permanent COVID-19 waivers that removed regulatory barriers to better patient care,…
Headline
The Food and Drug Administration July 28 extended to six months the shelf life for Johnson & Johnson’s COVID-19 vaccine. The decision is based on data from…
Headline
The Provider Relief Fund Deadline Extension Act (S. 2493/H.R. 4735) was introduced yesterday in the Senate and House. The AHA-supported bill would allow…
Headline
The AHA yesterday joined the U.S. Chamber of Commerce and American Medical Association in urging the 11th Circuit Court of Appeals to void a district court…